Search Results

There are 7491 results for: content related to: Prevention and Early Detection Clinical Trials: Opportunities for Primary Care Providers and Their Patients

  1. Role of inducible nitric oxide synthase in endothelium-independent relaxation to raloxifene in rat aorta

    British Journal of Pharmacology

    Volume 174, Issue 8, April 2017, Pages: 718–733, Chi Ming Wong, Chak Leung Au, Suk Ying Tsang, Chi Wai Lau, Xiaoqiang Yao, Zongwei Cai and Arthur Chi-Kong Chung

    Version of Record online : 27 FEB 2017, DOI: 10.1111/bph.13733

  2. Environmental fate and chemistry of raloxifene hydrochloride

    Environmental Toxicology and Chemistry

    Volume 21, Issue 4, April 2002, Pages: 729–736, Jerold Scott Teeter and Roger D. Meyerhoff

    Version of Record online : 5 NOV 2009, DOI: 10.1002/etc.5620210407

  3. Cardiovascular effects of raloxifene: the potential for cardiovascular protection in women

    Diabetes, Obesity and Metabolism

    Volume 4, Issue 3, May 2002, Pages: 166–176, N. K. Wenger

    Version of Record online : 30 MAY 2002, DOI: 10.1046/j.1463-1326.2002.00208.x

  4. Raloxifene reduces atherosclerosis: studies of optimized raloxifene doses in ovariectomized, cholesterol-fed rabbits

    Clinical Endocrinology

    Volume 52, Issue 2, February 2000, Pages: 225–233, Nina Hannover Bjarnason, Jens Haarbo, Inger Byrjalsen, Raymond F. Kauffman, Mary Pat Knadler and Claus Christiansen

    Version of Record online : 9 OCT 2006, DOI: 10.1046/j.1365-2265.2000.00919.x

  5. You have free access to this content
    Therapeutic concentrations of raloxifene augment nitric oxide-dependent coronary artery dilatation in vitro

    British Journal of Pharmacology

    Volume 152, Issue 2, September 2007, Pages: 223–229, F P Leung, L M Yung, H S Leung, C L Au, X Yao, P M Vanhoutte, I Laher and Y Huang

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0707387

  6. Raloxifene: Risks and Benefits

    Annals of the New York Academy of Sciences

    Volume 949, Issue 1, December 2001, Pages: 295–303, ELIZABETH BARRETT-CONNOR

    Version of Record online : 25 JAN 2006, DOI: 10.1111/j.1749-6632.2001.tb04036.x

  7. You have free access to this content
    Raloxifene acutely suppresses ventricular myocyte contractility through inhibition of the L-type calcium current

    British Journal of Pharmacology

    Volume 142, Issue 1, May 2004, Pages: 89–96, Reginald Liew, Mark A Stagg, Kenneth T MacLeod and Peter Collins

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0705736

  8. You have free access to this content
    Raloxifene protects endothelial cell function against oxidative stress

    British Journal of Pharmacology

    Volume 155, Issue 3, October 2008, Pages: 326–334, C M Wong, L M Yung, F P Leung, S-Y Tsang, C L Au, Z-Y Chen, X Yao, C H K Cheng, C-W Lau, M Gollasch and Y Huang

    Version of Record online : 29 JAN 2009, DOI: 10.1038/bjp.2008.262

  9. You have free access to this content
    Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study

    Journal of Bone and Mineral Research

    Volume 20, Issue 9, September 2005, Pages: 1514–1524, Ethel S Siris, Steven T Harris, Richard Eastell, Jose R Zanchetta, Stefan Goemaere, Adolfo Diez-Perez, John L Stock, Jingli Song, Yongming Qu, Pandurang M Kulkarni, Suresh R Siddhanti, Mayme Wong and Steven R Cummings

    Version of Record online : 16 MAY 2005, DOI: 10.1359/JBMR.050509

  10. Evolution of Selective Estrogen and Androgen Receptor Modulators: Status of Current Therapy and New Drug Development

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Gregory T. Wurz and Michael W. DeGregorio

    Published Online : 16 DEC 2011, DOI: 10.1002/9780470571224.pse462

  11. You have free access to this content
    Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (EFficacy of FOSAMAX® versus EVISTA®Comparison Trial) International

    Journal of Internal Medicine

    Volume 255, Issue 4, April 2004, Pages: 503–511, P. N. Sambrook, 1 P. Geusens, 2 C. Ribot, 3 J. A. Solimano, 4 J. Ferrer-Barriendos, 5 K. Gaines, 6 N. Verbruggen and 6 M. E. Melton 6

    Version of Record online : 22 MAR 2004, DOI: 10.1111/j.1365-2796.2004.01317.x

  12. You have free access to this content
    Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene Therapy

    Journal of Bone and Mineral Research

    Volume 17, Issue 1, January 2002, Pages: 1–10, Somnath Sarkar, Bruce H. Mitlak, Mayme Wong, John L. Stock, Dennis M. Black and Kristine D. Harper

    Version of Record online : 1 JAN 2002, DOI: 10.1359/jbmr.2002.17.1.1

  13. You have full text access to this OnlineOpen article
    Raloxifene inhibits hepatitis C virus infection and replication

    FEBS Open Bio

    Volume 2, Issue 1, January 01, 2012, Pages: 279–283, Midori Takeda, Masanori Ikeda, Kyoko Mori, Masahiko Yano, Yasuo Ariumi, Hiromichi Dansako, Takaji Wakita and Nobuyuki Kato

    Version of Record online : 22 AUG 2012, DOI: 10.1016/j.fob.2012.08.003

  14. You have free access to this content
    Bone Histomorphometric and Biochemical Marker Results of a 2-Year Placebo-Controlled Trial of Raloxifene in Postmenopausal Women

    Journal of Bone and Mineral Research

    Volume 17, Issue 2, February 2002, Pages: 341–348, Susan M. Ott, Anna Oleksik, Yili Lu, Kristine Harper and Paul Lips

    Version of Record online : 1 FEB 2002, DOI: 10.1359/jbmr.2002.17.2.341

  15. You have free access to this content
    Effects of UGT1A1*28 polymorphism on raloxifene pharmacokinetics and pharmacodynamics

    British Journal of Clinical Pharmacology

    Volume 67, Issue 4, April 2009, Pages: 437–444, Jurij Trontelj, Janja Marc, Andrej Zavratnik, Marija Bogataj and Aleš Mrhar

    Version of Record online : 21 JAN 2009, DOI: 10.1111/j.1365-2125.2009.03363.x

  16. Effects of raloxifene on the renin–angiotensin–aldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women

    Geriatrics & Gerontology International

    Volume 10, Issue 1, January 2010, Pages: 70–77, Hiroyuki Sumino, Shuichi Ichikawa, Shu Kasama, Takashi Takahashi, Hisao Kumakura, Yoshiaki Takayama, Tsugiyasu Kanda, Masami Murakami and Masahiko Kurabayashi

    Version of Record online : 8 OCT 2009, DOI: 10.1111/j.1447-0594.2009.00562.x

  17. Recent Results from Clinical Trials Using SERMs to Reduce the Risk of Breast Cancer

    Annals of the New York Academy of Sciences

    Volume 1089, Issue 1, November 2006, Pages: 127–142, VICTOR G. VOGEL

    Version of Record online : 11 DEC 2006, DOI: 10.1196/annals.1386.010

  18. You have free access to this content
    A randomised, double-blind trial comparing raloxifene HCl and continuous combined hormone replacement therapy in postmenopausal women: effects on compliance and quality of life

    BJOG: An International Journal of Obstetrics & Gynaecology

    Volume 109, Issue 8, August 2002, Pages: 874–885, Simon Voss, Deborah Quail, Alison Dawson, Tjorbörn Bäckström, Fernanda Aguas, Mithat Erenus, Hok Sien The, John Bonnar, Christian De Geyter, Myra Hunter, Thomas Nickelsen and for the Euralox Investigators Group

    Version of Record online : 22 DEC 2003, DOI: 10.1111/j.1471-0528.2002.01510.x

  19. RALOXIFENE, TAMOXIFEN AND VASCULAR TONE

    Clinical and Experimental Pharmacology and Physiology

    Volume 34, Issue 8, August 2007, Pages: 809–813, Fung Ping Leung, Suk Ying Tsang, Chi Ming Wong, Lai Ming Yung, Yau Chi Chan, Hok Sum Leung, Xiaoqiang Yao and Yu Huang

    Version of Record online : 26 JUN 2007, DOI: 10.1111/j.1440-1681.2007.04684.x

  20. You have free access to this content
    Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes

    British Journal of Pharmacology

    Volume 172, Issue 5, March 2015, Pages: 1379–1394, F Cerrato, M E Fernández-Suárez, R Alonso, M Alonso, C Vázquez, O Pastor, P Mata, M A Lasunción and D Gómez-Coronado

    Version of Record online : 8 JAN 2015, DOI: 10.1111/bph.13016